tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
VTI ETF Daily Update, 10/16/2025
PremiumMarket NewsVTI ETF Daily Update, 10/16/2025
14d ago
Positive Regulatory Environment and Strategic Alignment Boost Confidence in NRX Pharmaceuticals’ Buy Rating
Premium
Ratings
Positive Regulatory Environment and Strategic Alignment Boost Confidence in NRX Pharmaceuticals’ Buy Rating
14d ago
VTI ETF Daily Update, 10/14/2025
Premium
Market News
VTI ETF Daily Update, 10/14/2025
16d ago
NRx Pharmaceuticals (NASDAQ: NRXP) Re-files ANDA for Preservative-Free IV Ketamine KETAFREE(TM)
PremiumTipRanks NewswireNRx Pharmaceuticals (NASDAQ: NRXP) Re-files ANDA for Preservative-Free IV Ketamine KETAFREE(TM)
29d ago
NRx Pharmaceuticals re-files abbreviated NDA for KETAFR
Premium
The Fly
NRx Pharmaceuticals re-files abbreviated NDA for KETAFR
1M ago
NRX Pharmaceuticals Gains FDA Approval for KETAFREE™
Premium
Company Announcements
NRX Pharmaceuticals Gains FDA Approval for KETAFREE™
1M ago
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Closes Acquisition of Dura Medical
PremiumTipRanks NewswireNRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Closes Acquisition of Dura Medical
2M ago
NRX Pharmaceuticals Raises $8.8 Million in Stock Offering
Premium
Company Announcements
NRX Pharmaceuticals Raises $8.8 Million in Stock Offering
2M ago
NRx Pharmaceuticals, HOPE Therapeutics complete Dura Medical acquisition
Premium
The Fly
NRx Pharmaceuticals, HOPE Therapeutics complete Dura Medical acquisition
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100